OTC Sedative Effects Subject Of FDA/NTSB Meeting In November
This article was originally published in The Tan Sheet
Executive Summary
Data gathered at a November meeting on potential transportation risks associated with the use of sedating medicines by vehicle operators could bolster support for an FDA-mandated OTC switch of second-generation antihistamines.